Cargando…

Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital

BACKGROUND: Severe sepsis is recognized as an inflammatory response causing organ dysfunction in patients with infection. Antimicrobial therapy is the mainstay of treatment. There is an ongoing demand for local surveillance of sepsis aetiology and monitoring of empirical treatment recommendations. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Nygård, Siri Tandberg, Langeland, Nina, Flaatten, Hans K, Fanebust, Rune, Haugen, Oddbjørn, Skrede, Steinar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975934/
https://www.ncbi.nlm.nih.gov/pubmed/24588984
http://dx.doi.org/10.1186/1471-2334-14-121
_version_ 1782310211989536768
author Nygård, Siri Tandberg
Langeland, Nina
Flaatten, Hans K
Fanebust, Rune
Haugen, Oddbjørn
Skrede, Steinar
author_facet Nygård, Siri Tandberg
Langeland, Nina
Flaatten, Hans K
Fanebust, Rune
Haugen, Oddbjørn
Skrede, Steinar
author_sort Nygård, Siri Tandberg
collection PubMed
description BACKGROUND: Severe sepsis is recognized as an inflammatory response causing organ dysfunction in patients with infection. Antimicrobial therapy is the mainstay of treatment. There is an ongoing demand for local surveillance of sepsis aetiology and monitoring of empirical treatment recommendations. The present study was established to describe the characteristics, quality of handling and outcome of patients with severe sepsis admitted to a Norwegian university hospital. METHODS: A one year prospective, observational study of adult community acquired case-defined severe sepsis was undertaken. Demographics, focus of infection, microbiological findings, timing and adequacy of empirical antimicrobial agents were recorded. Clinical diagnostic practice was evaluated. Differences between categorical groups were analysed with Pearson’s chi-squared test. Predictors of in-hospital mortality were identified in a multivariate stepwise backward logistic regression model. RESULTS: In total 220 patients were identified, yielding an estimated annual incidence of 0.5/1000 inhabitants. The focus of infection was established at admission in 69%. Respiratory tract infection was present in 52%, while genitourinary, soft tissue and abdominal infections each were found in 12-14%. Microbiological aetiology was identified in 61%; most prevalent were Streptococcus pneumoniae, Escherichia coli and Staphylococcus aureus. Independent predictors of in-hospital mortality were malignancy, cardiovascular disease, endocarditis, abdominal infections, undefined microbiological aetiology, delay in administration of empirical antimicrobial agents ≥ 6 hours and use of inadequate antimicrobial agents. In patients ≥ 75 years, antimicrobial therapy was less in compliance with current recommendations and more delayed. CONCLUSIONS: Community acquired severe sepsis is common. Initial clinical aetiology is often revised. Compliance with recommendations for empirical antimicrobial treatment is lowest in elderly patients. Our results emphasizes that quick identification of correct source of infection, proper sampling for microbiological analyses, and fast administration of adequate antimicrobial agents are crucial points in the management of severe sepsis.
format Online
Article
Text
id pubmed-3975934
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39759342014-04-05 Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital Nygård, Siri Tandberg Langeland, Nina Flaatten, Hans K Fanebust, Rune Haugen, Oddbjørn Skrede, Steinar BMC Infect Dis Research Article BACKGROUND: Severe sepsis is recognized as an inflammatory response causing organ dysfunction in patients with infection. Antimicrobial therapy is the mainstay of treatment. There is an ongoing demand for local surveillance of sepsis aetiology and monitoring of empirical treatment recommendations. The present study was established to describe the characteristics, quality of handling and outcome of patients with severe sepsis admitted to a Norwegian university hospital. METHODS: A one year prospective, observational study of adult community acquired case-defined severe sepsis was undertaken. Demographics, focus of infection, microbiological findings, timing and adequacy of empirical antimicrobial agents were recorded. Clinical diagnostic practice was evaluated. Differences between categorical groups were analysed with Pearson’s chi-squared test. Predictors of in-hospital mortality were identified in a multivariate stepwise backward logistic regression model. RESULTS: In total 220 patients were identified, yielding an estimated annual incidence of 0.5/1000 inhabitants. The focus of infection was established at admission in 69%. Respiratory tract infection was present in 52%, while genitourinary, soft tissue and abdominal infections each were found in 12-14%. Microbiological aetiology was identified in 61%; most prevalent were Streptococcus pneumoniae, Escherichia coli and Staphylococcus aureus. Independent predictors of in-hospital mortality were malignancy, cardiovascular disease, endocarditis, abdominal infections, undefined microbiological aetiology, delay in administration of empirical antimicrobial agents ≥ 6 hours and use of inadequate antimicrobial agents. In patients ≥ 75 years, antimicrobial therapy was less in compliance with current recommendations and more delayed. CONCLUSIONS: Community acquired severe sepsis is common. Initial clinical aetiology is often revised. Compliance with recommendations for empirical antimicrobial treatment is lowest in elderly patients. Our results emphasizes that quick identification of correct source of infection, proper sampling for microbiological analyses, and fast administration of adequate antimicrobial agents are crucial points in the management of severe sepsis. BioMed Central 2014-03-04 /pmc/articles/PMC3975934/ /pubmed/24588984 http://dx.doi.org/10.1186/1471-2334-14-121 Text en Copyright © 2014 Nygård et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research Article
Nygård, Siri Tandberg
Langeland, Nina
Flaatten, Hans K
Fanebust, Rune
Haugen, Oddbjørn
Skrede, Steinar
Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital
title Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital
title_full Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital
title_fullStr Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital
title_full_unstemmed Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital
title_short Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital
title_sort aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a norwegian university hospital
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975934/
https://www.ncbi.nlm.nih.gov/pubmed/24588984
http://dx.doi.org/10.1186/1471-2334-14-121
work_keys_str_mv AT nygardsiritandberg aetiologyantimicrobialtherapyandoutcomeofpatientswithcommunityacquiredseveresepsisaprospectivestudyinanorwegianuniversityhospital
AT langelandnina aetiologyantimicrobialtherapyandoutcomeofpatientswithcommunityacquiredseveresepsisaprospectivestudyinanorwegianuniversityhospital
AT flaattenhansk aetiologyantimicrobialtherapyandoutcomeofpatientswithcommunityacquiredseveresepsisaprospectivestudyinanorwegianuniversityhospital
AT fanebustrune aetiologyantimicrobialtherapyandoutcomeofpatientswithcommunityacquiredseveresepsisaprospectivestudyinanorwegianuniversityhospital
AT haugenoddbjørn aetiologyantimicrobialtherapyandoutcomeofpatientswithcommunityacquiredseveresepsisaprospectivestudyinanorwegianuniversityhospital
AT skredesteinar aetiologyantimicrobialtherapyandoutcomeofpatientswithcommunityacquiredseveresepsisaprospectivestudyinanorwegianuniversityhospital